Your Source for Venture Capital and Private Equity Financings

Assort Health Announces $120M Series C

2026-07-23
SAN FRANCISCO, CA, Assort Health has announced a $120 million Series C financing, led by Menlo Ventures.
Assort Health, the most widely-used AI agents platform for the patient journey, today announced three senior executive hires, including Jon Corn as Chief Revenue Officer, Kristina Kemp as Vice President of Customer Success, and Emil Yeargin as Senior Vice President of People.

The leadership expansion follows Assort's $120 million Series C financing, led by Menlo Ventures, bringing total funding to $222 million, and comes just weeks after more than 200 healthcare leaders gathered at the company's annual Ascend customer summit.

Other participating investors included Lightspeed Venture Partners, Felicis, First Round Capital, and Tau Venture

Assort Health is the most-widely used AI agents platform for the patient journey, from scheduling and intake to referrals, forms, document processing, medication refills, and payments. It is built on 200 million specialty patient interactions and a model that updates in real time to handle the complexity of healthcare that general-purpose AI can't. That foundation now powers patient access across multi-site practices, multi-specialty groups, and health systems. Customers see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score. The platform integrates natively with leading EHR and practice management systems, including Epic and Athena, enabling deployment without disrupting existing clinical workflows. Provider groups and health systems turn to Assort when the complexity outgrows their existing tools.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors